Larotrectinib is the world’s first highly selective neurotrophic tyrosine receptor kinase (TRK) inhibitor and a tissue-agnostic precision targeted antineoplastic agent.
Authentic
Guarantee
Fast Delivery
Privacy Copyright2024@ BIGBEAR All right reserved BIGBEAR



